Skip to main content
. 2021 Jun 21;10(6):1562. doi: 10.3390/cells10061562

Figure 4.

Figure 4

Eritoran did not reduce hepatic steatosis or systemic insulin resistance in the FFD-fed mice. (A) Serum cholesterol (chol), insulin and glucose levels. (B) Hepatic triglyceride (TG) levels. (C) Oil Red O staining of the liver sections and quantification of the stained areas (%). Scale bar = 50 μm. Tissue sections from all the mice were stained and quantified (means ± SEM). (D) Glucose tolerance testing (GTT) and insulin tolerance testing (ITT) of the groups. AUC: area under the curve. NCD-V/NCD-E: the mice fed a normal chow diet (NCD) were injected with a vehicle (NCD-V, n = 6) or eritoran (NCD-E, n = 6); FFD-V/FFD-E: the mice fed a fast-food diet (FFD) were injected with a vehicle (FFD-V, n = 10) or eritoran (FFD-E, n = 9); # p < 0.05 vs. NCD-V.